Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells (Q69024451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

author name string

J J Mulé

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

S L Schwarz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

A B Roberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

M B Sporn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

S A Rosenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

95-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00205600

29 September 2019

exact match

0 references

cites work

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

1 reference

12 December 2020

An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumors

1 reference

12 December 2020

Increased secretion of type beta transforming growth factor accompanies viral transformation of cells

1 reference

12 December 2020

Enhancement of tumor outgrowth by tumor-associated blocking factors

1 reference

12 December 2020

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

12 December 2020

Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia

1 reference

12 December 2020

Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes

1 reference

12 December 2020

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

12 December 2020

Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells

1 reference

12 December 2020

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor

1 reference

12 December 2020

In vitro growth of cytotoxic human lymphocytes. I. Growth of cells sensitized in vitro to alloantigens

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors

1 reference

12 December 2020

Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization

1 reference

12 December 2020

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues

1 reference

12 December 2020

Purification and characterization of two cartilage-inducing factors from bovine demineralized bone

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness

1 reference

12 December 2020

In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor

1 reference

12 December 2020

Transforming growth factor-beta: biological function and chemical structure

1 reference

12 December 2020

Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2

1 reference

12 December 2020

Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines

1 reference

12 December 2020

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes

1 reference

12 December 2020

Serologic Identification of Multiple Tumor-Associated Antigens on Murine Sarcomas

1 reference

12 December 2020

Transforming growth factors from neoplastic and nonneoplastic tissues

1 reference

12 December 2020

Presence of immunosuppressive factors in brain-tumor cyst fluid.

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

12 December 2020

In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells

1 reference

12 December 2020

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

1 reference

12 December 2020

The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma

1 reference

12 December 2020

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells

1 reference

12 December 2020

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

1 reference

12 December 2020

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

12 December 2020

Inhibition of interleukin 2 production by factors released from tumor cells.

1 reference

12 December 2020

The fate of interleukin-2 after in vivo administration

1 reference

12 December 2020

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

12 December 2020

Inhibition of cytokine production by a tumor cell product.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2452015%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 September 2019

0 references

1 reference